Your browser doesn't support javascript.
loading
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin.
Nakano, Kenji; Fukuda, Naoki; Sato, Yasuyoshi; Urasaki, Tetsuya; Ohmoto, Akihiro; Wang, Xiaofei; Hayashi, Naomi; Suto, Hirotaka; Udagawa, Shohei; Oki, Ryosuke; Yunokawa, Mayu; Ono, Makiko; Tomomatsu, Junichi; Minami, Yusuke; Hayakawa, Keiko; Tanizawa, Taisuke; Ae, Keisuke; Matsumoto, Seiichi; Takahashi, Shunji.
Affiliation
  • Nakano K; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Fukuda N; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Sato Y; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Urasaki T; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Ohmoto A; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Wang X; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Hayashi N; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Suto H; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Udagawa S; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Oki R; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Yunokawa M; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Ono M; Departments of Gynecology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Tomomatsu J; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Minami Y; Departments of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Hayakawa K; Departments of Orthopedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Tanizawa T; Departments of Orthopedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Ae K; Departments of Orthopedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Matsumoto S; Departments of Orthopedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
  • Takahashi S; Departments of Orthopedic Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto, Japan.
Oncology ; 100(4): 238-246, 2022.
Article in En | MEDLINE | ID: mdl-35100601
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Soft Tissue Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Oncology Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Soft Tissue Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Oncology Year: 2022 Document type: Article Affiliation country: